Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Sernova ( (TSE:SVA) ) has issued an announcement.
Sernova Corp. announced the results of its recent annual and special meeting of shareholders, where key resolutions were approved, including the election of directors, the appointment of KPMG LLP as auditors, and an increase in the number of common shares reserved for stock option grants. The company expressed confidence in moving into a new era with strengthened leadership and an optimistic outlook for its future growth and development.
More about Sernova
Sernova Corp. is a leading regenerative medicine company that focuses on developing its Cell Pouch bio-hybrid organ technology, primarily targeting a functional cure for type 1 diabetes.
YTD Price Performance: -2.17%
Average Trading Volume: 110,628
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$73.91M
For detailed information about SVA stock, go to TipRanks’ Stock Analysis page.
